Achieving Clinical Remission for Patients With Rheumatoid Arthritis

被引：17
|
作者：
Aletaha, Daniel [1 ]
Smolen, Josef S. [1 ]
机构：
[1] Med Univ Vienna, Dept Med, Div Rheumatol, Vienna, Austria
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2019年 / 321卷 / 05期
关键词：
LOW DISEASE-ACTIVITY; ULTRASOUND; PROGRESSION; TARGET; DAMAGE;
D O I：
10.1001/jama.2018.21249
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：457 / 458
页数：2
相关论文
共 50 条
  • [41] PRESENCE OF ANTIBODIES TO ADALIMUMAB AND INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL REMISSION
    Eng, G.
    Fana, V.
    Omerovic, E.
    Hojsgaard, P.
    Lindegaard, H. M.
    Jensen, E. K.
    Bouchelouche, P. N.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 230 - 230
  • [42] ATTEMPTING WITHDRAWAL OF ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO ARE IN CLINICAL REMISSION
    Kamiya, M.
    Sohen, S.
    Kikuchi, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 519 - 520
  • [43] Remission for rheumatoid arthritis patients on anti-TNF in clinical practice
    Murphy, Kevin
    Butt, Sayqa
    Gadsby, Kate
    Deighton, Chris
    RHEUMATOLOGY, 2008, 47 : II40 - II40
  • [44] Healthcare Costs of Not Achieving Remission in Patients with Rheumatoid Arthritis in the United States: A Retrospective Cohort Study
    Bergman, Martin
    Zhou, Lili
    Patel, Pankaj
    Sawant, Ruta
    Clewell, Jerry
    Tundia, Namita
    ADVANCES IN THERAPY, 2021, 38 (05) : 2558 - 2570
  • [45] A STUDY ON CHARACTERISTICS OF RHEUMATOID ARTHRITIS PATIENTS ACHIEVING HAQ REMISSION WITH 6 MONTHS OF BIOLOGIC TREATMENT
    Miwa, Y.
    Takahashi, R.
    Yajima, N.
    Wakabayashi, K.
    Tokunaga, T.
    Ishii, S.
    Nishimi, A.
    Kasama, T.
    Oh, K.
    Toyoshima, Y.
    Inagaki, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1003 - 1003
  • [46] Healthcare Costs of Not Achieving Remission in Patients with Rheumatoid Arthritis in the United States: A Retrospective Cohort Study
    Martin Bergman
    Lili Zhou
    Pankaj Patel
    Ruta Sawant
    Jerry Clewell
    Namita Tundia
    Advances in Therapy, 2021, 38 : 2558 - 2570
  • [47] A study on characteristics of rheumatoid arthritis patients achieving remission in depression with 6 months of bDMARDs treatment
    Miwa, Yusuke
    Ikari, Yuzo
    Hosonuma, Masahiro
    Hatano, Mika
    Hayashi, Tomoki
    Kasama, Tsuyoshi
    Sanada, Kenji
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2018, 5 (02) : 111 - 114
  • [48] ACPA and RF As Predictors of Sustained Clinical Remission in Rheumatoid Arthritis Patients: Data from a Rheumatoid Arthritis Cohort
    Pope, Janet E.
    Rampakakis, Emmanouil
    Movahedi, Mohammad
    Cesta, Angela
    Sampalis, John S.
    Bombardier, Claire
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [49] Economic benefit of achieving clinical and radiographic remission with etanercept as first line treatment in severe and highly active rheumatoid arthritis patients
    Fautrel, Bruno
    Maravic, Milka
    Daures, Jean-Pierre
    Miadi-Fargier, Honda
    Le Pen, Claude
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S462 - S462
  • [50] Characteristics of patients with rheumatoid arthritis in clinical remission: the many aspects of DAS28 remission
    Son, K. M.
    Song, S. H.
    Lim, S. K.
    Seo, Y. I.
    Kim, H. A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (06) : 947 - 950
12345